Further improving research quality in cancer management by integration of traditional Chinese medicine and modern medicineSUN Yan1588-1591,1611
Targeted therapy for non-small-cell lung cancer using EGFR-TKIsTAN Fen-lai, WANG Yin-xiang, YUAN Xiao-fen, DING Lie-ming, HU Bei, ZHANG Li, ZHOU Jian-ying, SHENG-TU Jian-zhong, SUN Yan1594-1601
Pharmacological effects and clinical research of the new drug crizotinib for treating lung cancerWANG Yan, YU Shu-fei1602-1607
Consideration of exposure-response relationships during clinical trials of new drugsWEI Min-ji, ZHAO Ming, SHAN Ai-lian1608-1611
Comparison of Chinese clinical trial regulation system with relevant international lawYAN Yong-bo, LI Ye1612-1614,1619
Application status of small molecule targeted anti-cancer drugs in ChinaCHEN Xiao-yuan, ZHANG Hong, GAO Chen-yan, YANG Zhi-min1615-1619
Progress in the study of T cell-dependent antibody responseHUO Yan, AI Wen-chao, Miao Yu-fa, Shen Lian-zhong, LI Bo1620-1623,1672
Central composite design optimizes preparation of norcantharidin-loaded chitosan-fibroin microspheres for embolizationZHANG Guang-yu, CHI Mei-yu, NI Jing, CHEN Yuan-lan, SONG Yu-ling, WANG Xiao-qing, ZHANG Xue-nong1624-1630
Preparation of lactosyl-norcantharitin phospholipid complex and its pH-sensitive liposomesZHOU Yi, XU Jing-yu, GUAN Min, ZHANG Xue-nong1631-1638
Traditional Chinese medicine and cancer:historic deposits and 50-years innovation and developmentLIN Hong-sheng, ZHANG Ying1639-1642